The IGG4-Related Disease Market is poised for substantial growth, projected to expand from USD 2.67 billion in 2024 to USD 6.08 billion by 2035. This remarkable trajectory corresponds to a compound annual growth rate (CAGR) of 7.78%. Such figures underscore the increasing recognition and diagnosis of this complex autoimmune condition, with healthcare systems scrambling to adapt to mounting...